Literature DB >> 8873439

Cadaver kidney transplantation in patients more than 65 years old.

J M Barry1, M J Lemmers, M M Meyer, A DeMattos, W M Bennett, D J Norman.   

Abstract

Elderly patients with end-stage renal disease often remain on dialytic therapy because they are at increased risk for mortality and morbidity. We placed 24 cadaver kidney transplants into 24 patients aged 65-74 years between September 1, 1985, and August 31, 1995. Rates of patient and graft survival were compared with those of 404 concurrent first cadaver-kidney transplant recipients between the ages of 20 and 44 years. The 5-year rates of patient and graft survival were not significantly different (86% versus 92% and 77% versus 63%, respectively; study group presented first). Primary cadaver kidney transplantation can be successfully performed in patients older than 65 years when a selection algorithm is applied to exclude active infection, active malignancy, unsuitable anatomy for technical success, high probability of operative mortality, and noncompliance. Pelvic arteriosclerosis and lower urinary tract abnormalities can cause intraoperative technical problems.

Entities:  

Mesh:

Year:  1996        PMID: 8873439     DOI: 10.1007/bf00182075

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

1.  Orthotopic renal transplant and results in 139 consecutive cases.

Authors:  J M Gil-Vernet; A Gil-Vernet; A Caralps; P Carretero; R Talbot-Wright; J Andreu; J A Campos
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

Review 2.  Venous thromboembolism.

Authors:  D W Brenner; M A Fogle; P F Schellhammer
Journal:  J Urol       Date:  1989-12       Impact factor: 7.450

3.  Internal marsupialization of lymphoceles after renal transplantation.

Authors:  J M Buckingham; J Roses; H Zincke
Journal:  Urology       Date:  1976-05       Impact factor: 2.649

4.  Should older patients receive renal transplants?

Authors:  J D Briggs
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

5.  Unstented extravesical ureteroneocystostomy in kidney transplantation.

Authors:  J M Barry
Journal:  J Urol       Date:  1983-05       Impact factor: 7.450

6.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

Authors:  H H Balfour; B A Chace; J T Stapleton; R L Simmons; D S Fryd
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

7.  Prospective risk stratification in renal transplant candidates for cardiac death.

Authors:  A Le; R Wilson; K Douek; L Pulliam; D Tolzman; D Norman; J Barry; W Bennett
Journal:  Am J Kidney Dis       Date:  1994-07       Impact factor: 8.860

8.  Immunological studies of ageing. X. Impaired T lymphocytes and normal monocyte response from elderly humans to the mitogenic antibodies OKT3 and Leu 4.

Authors:  R Schwab; P B Hausman; E Rinnooy-Kan; M E Weksler
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

Review 9.  Renal replacement therapies in the elderly: Part II. Renal transplantation.

Authors:  N Ismail; R M Hakim; J H Helderman
Journal:  Am J Kidney Dis       Date:  1994-01       Impact factor: 8.860

10.  Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.

Authors:  A P Disney
Journal:  Am J Kidney Dis       Date:  1995-01       Impact factor: 8.860

View more
  3 in total

Review 1.  Immunosuppression in older renal transplant patients.

Authors:  J M Morales; J M Campistol; A Andrés; J C Herrero
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 2.  Renal transplantation in the elderly.

Authors:  J S Cameron
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

Review 3.  Renal transplantation in patients above 60 years of age in the modern era: a single center experience with a review of the literature.

Authors:  A Basu; S M Greenstein; S Clemetson; M Malli; D Kim; R Schechner; P Gerst; V A Tellis
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.